To the Editor: Methemoglobinemia is suspected in any cyanotic newborn, in whom cyanotic congenital heart disease and respiratory disease have been ruled out. The drugs causing acquired methemoglobinemia include those with oxidant properties such as dapsone, anesthetic agents and inhaled nitric oxide [1] . We present three cases of methemoglobinemia developing in neonates who were treated with broad spectrum antibiotics.
Case 1: A female baby who received tigecycline and imipenem for 9 d was referred to our hospital with respiratory distress on Day 14 of life. Saturation in room air and with oxygen supplementation was 82%. Arterial blood gas (ABG) showed good oxygenation with partial pressure of oxygen (PaO 2 ) of 299 mmHg. Methemoglobin level done was 43.6%. Case 2: A male baby who received vancomycin, meropenem and tigecycline for 7 d, developed cyanosis on Day 10 of life and was referred to our hospital. Saturation in room air was 86% which did not improve with oxygen administration. Methemoglobin level was 41.3%. Case 3: A female baby whose blood culture grew Burkholderia cepacia, was given IV meropenem for 6 d. On Day 8, baby developed cyanosis and was referred to us. Saturation in room air and with oxygen supplementation was 85%. ABG done showed increased PaO 2 . Methemoglobin levels done were 11%.
All 3 babies were started on Vitamin C supplementation and improved clinically. Methemoglobin levels at discharge and on follow-up showed a decreasing trend.
Acquired methemoglobinemia is due to increased methemoglobin formation by exogenously administered agents such as benzocaine and nitrate solutions [2, 3] . The drugs usually implicated in causing methemoglobinemia have a free nitrate group which can oxidize the ferrous moiety in hemoglobin to the ferric form. Though broad spectrum antibiotics like tigecycline and meropenem do not have a free nitrate group, these 3 neonates who had been treated with higher antibiotics went on to develop methemoglobinemia. Further studies might be needed to prove the causal relationship of the same.
We would like to sensitize practicing pediatricians on the need to exhibit caution when considering broad spectrum antibiotic usage in neonates, so that a potentially fatal illness like methemoglobinemia can be prevented.
